UN Leads Bid For Cheaper Insulin, Expanding Access For Diabetics Worldwide
Mohammad Ali (@ChaudhryMAli88) Published November 14, 2019 | 12:30 AM
UNITED NATIONS, (UrduPoint / Pakistan Point News - 14th Nov, 2019 ) :Overly expensive insulin could be a thing of the past � and life-changing news � for millions of diabetics under a plan launched by the World Health Organization on Wednesday to diversify production globally, according to a WHO press release.
Announcing the initiative in Geneva just ahead of World Diabetes Day, the UN agency said that it had already had informal expressions of interest from pharmaceutical companies looking to produce insulin and have WHO assess whether it is safe for people to use.
"The simple fact is, that the prevalence of diabetes is growing, the amount of insulin available to treat diabetes is too low, the prices are too high, so we need to do something," Emer Cooke, Director of Regulation of Medicines and other Health Technologies at WHO, said.
Coinciding with the project launch, which comes ahead of World Diabetes Day marked each 14 November, UN Secretary-General Antonio Guterres highlighted the impact of "catastrophic" medical expenses on sufferers.
"Diabetes damages health and undermines educational and employment aspirations for many, affecting communities and forcing families into economic hardship", he said, particularly in low and middle-income countries.
The WHO's two-year pilot project, unveiled on Wednesday, involves the evaluation of insulin developed by manufacturers to ensure their quality, safety, efficacy and affordability.
Assuming there is enough interest from manufacturers and, crucially, more insulin available for diabetics, the scheme could be expanded more widely.
"We're going to look at the number of companies that will apply, we're going to look at how long it takes, we're going to look at the outcomes and we're going to see whether this makes sense and it really is increasing access", Ms. Cooke said.
The procedure is known as prequalification and WHO has done it in the past for non-brand vaccines, including those used to treat TB, malaria and HIV.
This had resulted in massive savings for sufferers around the world, with 80 per cent of HIV patients now relying on generic products, Ms.
Cooke said.
She noted too that some companies had already committed to lowering prices.
"When (HIV) anti-retrovirals were first produced, the cost per patient per year was $10,000," she said. "Once we opened prequalification for generic HIV products, the price went down to $300 per year." She added: "We're also confident that competition will bring prices down. That way, countries will have a greater choice of products that are more affordable." Today, three manufacturers control most of the global market for insulin, which was discovered as a treatment for diabetes in 1921.
The medicine works by lowering blood glucose levels, a task that is usually carried out by natural insulin, which is produced by the pancreas whenever we eat.
The quadrupling in the number of people with diabetes since 1980 � to around 420 million today, mostly in low and middle-income countries - is widely attributed to poor diet and a lack of exercise.
Those with type one diabetes � around 20 million people - need insulin injections to survive, while only around half of the 65 million type-two sufferers who need insulin are able to get it, WHO said.
In some countries, prices are so prohibitive that some people are forced to ration their insulin.
This leaves them susceptible to heart attacks, stroke, kidney failure, blindness and lower limb amputations.
And while diabetes was the seventh leading cause of death globally in 2016, the finding is only worrying because the disease kills people prematurely, said Dr Gojka Roglic, WHO medical officer and diabetes expert.
"We all have to die of something and why not of diabetes - but (only) after celebrating our 90th birthday," she joked. "The problem with diabetes is that it accounts for a large proportion of premature diabetes � almost half of them occur before 70." In low and middle-income countries, the percentage rises to around 60 per cent, Dr Roglic added.
Data collected by WHO from 24 countries on four continents showed that human insulin was available only in 61 per cent of health facilities.
Related Topics
Recent Stories
Naqvi directs foolproof measures for protection of Chinese nationals
Israel carries out attack inside Iran, report US media
Saudi Assistant Minister of Defence calls on army chief
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 19 April 2024
Today Gold Rate in Pakistan 19 April 2024
Rock-solid Ruud racks up season-leading win in Barcelona
At UN, Iran says it will make Israel 'regret' reprisals
G7 hears calls for 'critical' Ukraine aid
EU seeks to leverage might to confront China, US challenge
5 Customs officials martyred as their vehicle ambushed by terrorists in D I Khan
Pak-New Zealand match called off due to rain
NHA restores traffic on roads affected by recent rains in Balochistan
More Stories From Miscellaneous
-
Transforming education sector: from job hunters to job creators
4 hours ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
4 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
5 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
5 days ago -
Radio Bahawalpur presents program “Eidi Shidi”
8 days ago -
Radio Bahawalpur to broadcast Eid programs
10 days ago
-
DC, DPO Haripur inspect bus terminals to review fares compliance
12 days ago -
Second phase of refugees’ repatriation to start after Eidul Fitr vacations
12 days ago -
Reaping bounties as Ramazan culminates
12 days ago -
Digital transformation – a boon or bane
12 days ago -
Plants’ business: Another casualty of climate change
14 days ago -
Eid shoppers prioritize children’s joy over personal comforts
14 days ago